InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024 - Seite 2

Dr. Maurer trained at Beth Israel Deaconess Hospital and Harvard Medical School in Boston (1995-1998) and is board certified for Dermatology (2000) and Allergology (2003).

Christopher Sayed, MD
Professor of Dermatology, University of North Carolina, Medical School, and Secretary of the HS Foundation

Dr. Sayed is an internationally recognized global key opinion leader in the field of hidradenitis suppurativa (HS) and has previously served as a board member of the US HS foundation.

Dr. Sayed has over 10 years of experience in the field of dermatology and clinical research with a special interest in the medical and surgical management of hidradenitis suppurativa (HS). He is the Medical Director of the HS clinic at University of North Carolina, Chapel Hill, NC, USA. He has performed clinical and basic science research in HS and other dermatologic conditions with more than 65 publications in the medical literature. He serves as a directing member of the Hidradenitis Suppurativa Foundation and is medical lead of a local HS support group. He is board certified in Dermatology and received his medical training at the University of North Carolina, USA.

Prof. Dr. Jörg Köhl
Director of the Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany

Dr. Köhl is an internationally leading translational complement scientist with a particular focus on the role of C5a/C5aR biology and its role in human disease.

He has over 30 years of medical and research experience and has published over 200 papers in the complement therapeutic landscape. His research has been continuously funded by the National Institutes of Health, the German Research Foundation, the Federal Ministry of Education and Research and the European Union since 1990. He has held several senior scientific positions, including a 20-year research appointment as Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center in the Divisions of Molecular Immunology and Immunobiology and his current position as the Founding Director of the Institute for Systemic Inflammation Research at the University of Lübeck, Germany. Dr. Köhl received his medical degree from the University of Mainz, Germany.